These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18678830)

  • 1. Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.
    Bosca I; Pascual AM; Casanova B; Coret F; Sanz MA
    Neurology; 2008 Aug; 71(6):457-8. PubMed ID: 18678830
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
    Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone-related acute leukemia in two MS patients.
    Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
    Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
    Ko MW; Tamhankar MA; Volpe NJ; Porter D; McGrath C; Galetta SL
    J Neurol Sci; 2008 Oct; 273(1-2):144-7. PubMed ID: 18687447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
    Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
    Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
    Ellis R; Boggild M
    Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis.
    Ledda A; Caocci G; Spinicci G; Cocco E; Mamusa E; La Nasa G
    Leukemia; 2006 Dec; 20(12):2217-8. PubMed ID: 17051242
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.
    Cattaneo C; Almici C; Borlenghi E; Motta M; Rossi G
    Leukemia; 2003 May; 17(5):985-6. PubMed ID: 12750718
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.
    Novoselac AV; Reddy S; Sanmugarajah J
    Leukemia; 2004 Sep; 18(9):1561-2. PubMed ID: 15215874
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.
    Hasan SK; Buttari F; Ottone T; Voso MT; Hohaus S; Marasco E; Mantovani V; Garagnani P; Sanz MA; Cicconi L; Bernardi G; Centonze D; Lo-Coco F
    Neurology; 2011 Mar; 76(12):1059-65. PubMed ID: 21346221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
    Vicari AM; Ciceri F; Folli F; Lanzi R; Colombo B; Comi G; Camba L
    Leukemia; 1998 Mar; 12(3):441-2. PubMed ID: 9529141
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
    Taube F; Stölzel F; Thiede C; Ehninger G; Laniado M; Schaich M
    Haematologica; 2011 Jun; 96(6):e31. PubMed ID: 21632839
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
    Sumrall A; Dreiling B
    J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
    Colovic N; Suvajdzic N; Kraguljac Kurtovic N; Djordjevic V; Dencic Fekete M; Drulovic J; Vidovic A; Tomin D
    Biomed Pharmacother; 2012 Apr; 66(3):173-4. PubMed ID: 22440894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukaemia induced by mitoxantrone: case report.
    Arruda WO; Montú MB; de Oliveira Mde S; Ramina R
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):327-9. PubMed ID: 16100984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia.
    Pecci A; Invernizzi R
    Haematologica; 2001 Jan; 86(1):102-3. PubMed ID: 11146580
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy-related acute promyelocytic leukaemia.
    Fenaux P; Detourmignies L
    Br J Haematol; 1994 Jun; 87(2):445. PubMed ID: 7947301
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.
    Sadiq SA; Rammal M; Sara G
    Mult Scler; 2008 Mar; 14(2):272-3. PubMed ID: 17986509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia.
    Cartwright MS; Jeffery DR; Lewis ZT; Koty PP; Stewart WT; Molnár I
    Neurology; 2007 May; 68(19):1630-1. PubMed ID: 17485652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.